Eugene Nikitin

1.1k total citations
62 papers, 301 citations indexed

About

Eugene Nikitin is a scholar working on Genetics, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Eugene Nikitin has authored 62 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Genetics, 20 papers in Pathology and Forensic Medicine and 18 papers in Molecular Biology. Recurrent topics in Eugene Nikitin's work include Chronic Lymphocytic Leukemia Research (42 papers), Lymphoma Diagnosis and Treatment (20 papers) and Immunodeficiency and Autoimmune Disorders (11 papers). Eugene Nikitin is often cited by papers focused on Chronic Lymphocytic Leukemia Research (42 papers), Lymphoma Diagnosis and Treatment (20 papers) and Immunodeficiency and Autoimmune Disorders (11 papers). Eugene Nikitin collaborates with scholars based in Russia, United States and Ukraine. Eugene Nikitin's co-authors include Andrey Sudarikov, Ancha Baranova, В. В. Птушкин, Аndrey S. Glotov, Oleg S. Glotov, А. В. Чудинов, Anastasia A. Ignatova, G. А. Novichkova, Mikhail A. Panteleev and Bella Biderman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and FEBS Letters.

In The Last Decade

Eugene Nikitin

51 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eugene Nikitin Russia 8 134 118 76 73 50 62 301
Katharina Lisenko Germany 13 104 0.8× 52 0.4× 48 0.6× 128 1.8× 41 0.8× 24 309
Fernando Solano Spain 7 92 0.7× 103 0.9× 122 1.6× 56 0.8× 60 1.2× 16 268
Caylib Durand Canada 9 79 0.6× 83 0.7× 85 1.1× 55 0.8× 158 3.2× 15 328
Raúl Gabus Uruguay 10 152 1.1× 133 1.1× 83 1.1× 73 1.0× 149 3.0× 24 366
Manfred Ahlgrimm Germany 8 76 0.6× 56 0.5× 58 0.8× 49 0.7× 50 1.0× 17 272
Pasquale L. Fedele Australia 11 118 0.9× 77 0.7× 127 1.7× 125 1.7× 100 2.0× 24 388
Loïc Renaud France 7 75 0.6× 75 0.6× 68 0.9× 40 0.5× 35 0.7× 17 222
Kazutaka Ozeki Japan 11 124 0.9× 98 0.8× 33 0.4× 242 3.3× 56 1.1× 42 385
Ryan J. Stubbins Canada 9 94 0.7× 81 0.7× 37 0.5× 102 1.4× 43 0.9× 26 286
Hyewon Lee South Korea 12 127 0.9× 88 0.7× 62 0.8× 220 3.0× 46 0.9× 38 424

Countries citing papers authored by Eugene Nikitin

Since Specialization
Citations

This map shows the geographic impact of Eugene Nikitin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugene Nikitin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugene Nikitin more than expected).

Fields of papers citing papers by Eugene Nikitin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugene Nikitin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugene Nikitin. The network helps show where Eugene Nikitin may publish in the future.

Co-authorship network of co-authors of Eugene Nikitin

This figure shows the co-authorship network connecting the top 25 collaborators of Eugene Nikitin. A scholar is included among the top collaborators of Eugene Nikitin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugene Nikitin. Eugene Nikitin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Птушкин, В. В., et al.. (2023). The Features of COVID-19’s Course and the Efficacy of the Gam-COVID-Vac Vaccine in Patients with Paroxysmal Nocturnal Hemoglobinuria. SHILAP Revista de lepidopterología. 15(3). 503–512. 2 indexed citations
4.
Nikitin, Eugene, et al.. (2022). Possibilities of targeted therapy for myelofibrosis: Moscow experience. SHILAP Revista de lepidopterología. 17(4). 94–105. 1 indexed citations
5.
6.
Nikitin, Eugene, et al.. (2022). Structure and prognostic signifi cance of 13q14 deletion in chronic lymphocytic leukemia. 67(1). 75–89. 2 indexed citations
7.
Cochrane, Tara, Alicia Enrico, David Gómez‐Almaguer, et al.. (2021). Impact of venetoclax monotherapy on the quality of life of patients with relapsed or refractory chronic lymphocytic leukemia: results from the phase 3b VENICE II trial. Leukemia & lymphoma. 63(2). 304–314. 6 indexed citations
8.
Biderman, Bella, et al.. (2021). Repertoire of Rearranged Immunoglobulin Heavy Chain Genes in Russian Patients With B-Cell Lymphoproliferative Diseases. Clinical Lymphoma Myeloma & Leukemia. 21(12). e938–e945. 5 indexed citations
9.
Olisova, Olga Yu., et al.. (2020). Cutaneous manifestations of B-cell chronic lymphocytic leukemia. International Journal of Hematology. 112(4). 459–465. 10 indexed citations
10.
Nikitin, Eugene, Anastasia A. Ignatova, Vladimir Vorobyev, et al.. (2020). Platelet function and bleeding in chronic lymphocytic leukemia and mantle cell lymphoma patients on ibrutinib. Journal of Thrombosis and Haemostasis. 18(10). 2672–2684. 18 indexed citations
11.
Cochrane, Tara, Tatiana Chagorova, Tadeusz Robak, et al.. (2018). Venetoclax Improves Quality of Life for Patients with Elapsed/Refractory Chronic Lymphocytic Leukemia. Blood. 132(Supplement 1). 4858–4858. 3 indexed citations
12.
Biderman, Bella, et al.. (2017). V(D)J Recombination Excision Circles of B- and T-cells as Prognostic Marker in B-Cell Chronic Lymphocytic Leukemia. Clinical oncohematology. 10(2). 131–140. 3 indexed citations
13.
14.
Nikitin, Eugene. (2014). B-Cell Receptor Signaling Pathway: Mechanisms and Inhibitors. Clinical oncohematology. 7(3). 251–263.
15.
Nikitin, Eugene, et al.. (2013). Chronic lymphocytic leukemia and renal cell carcinoma: literature review and case reports. SHILAP Revista de lepidopterología. 6(1). 69–74. 1 indexed citations
16.
Nikitin, Eugene, et al.. (2013). New markers (CD160, CD200, and LAIR-1) in diagnosis of B-cell lymphoproliferative disorders. SHILAP Revista de lepidopterología. 6(1). 46–52.
17.
Leprêtre, Stéphane, Ann Janssens, Véronique Leblond, et al.. (2011). The value of rituximab for the treatment of fludarabine-refractory chronic lymphocytic leukemia: a systematic review and qualitative analysis of the literature. Leukemia & lymphoma. 53(5). 820–829. 4 indexed citations
18.
Biderman, Bella, Andrey V. Marakhonov, Mikhail Skoblov, et al.. (2010). Inhibition of potassium currents as a pharmacologic target for investigation in chronic lymphocytic leukemia. Drug News & Perspectives. 23(10). 625–625. 1 indexed citations
19.
Birerdinc, Aybike, Andrey V. Marakhonov, Ganiraju C. Manyam, et al.. (2009). Pro-apoptotic and antiproliferative activity of human KCNRG, a putative tumor suppressor in 13q14 region. Tumor Biology. 31(1). 33–45. 18 indexed citations
20.
Ivanov, Dmitry, Loïc Lemonnier, Н. В. Кононенко, et al.. (2003). A new human gene KCNRG encoding potassium channel regulating protein is a cancer suppressor gene candidate located in 13q14.3. FEBS Letters. 539(1-3). 156–160. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katharina Lisenko Breakdown of academic impact, for papers by Fernando Solano Breakdown of academic impact, for papers by Caylib Durand Breakdown of academic impact, for papers by Raúl Gabus Breakdown of academic impact, for papers by Manfred Ahlgrimm Breakdown of academic impact, for papers by Pasquale L. Fedele Breakdown of academic impact, for papers by Loïc Renaud Breakdown of academic impact, for papers by Kazutaka Ozeki Breakdown of academic impact, for papers by Ryan J. Stubbins Breakdown of academic impact, for papers by Hyewon Lee
Rankless by CCL
2026